Slate Path Capital LP
SEC insider (Form 3/4/5 filer). CIK 0001559706. 10% Owner at Cyclerion Therapeutics, Inc. (CYCN). 1 reported Form 4/5 transaction since Sep 2024; latest on Nov 21, 2024. Located in NEW YORK, NY.
Companies Slate Path Capital LP has filed insider reports for
- Cyclerion Therapeutics, Inc. (CYCN): 10% Owner
Slate Path Capital LP
CIK: 0001559706
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CYCN
Cyclerion Therapeutics, Inc.
10% Owner